NR-NO2
NR-NO2 is a potential drug with targeted release and imaging-based guidance in antitumor research. NR-NO2 has an anti-bacterial effect[1].
Product Specifications
CAS Number
3033874-97-1
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nr-no2.html
Solubility
10 mM in DMSO
Smiles
CC1=CC(COC(OC2=CC=C3C4(C5=C(OC3=C2)C=C(N(CC)CC)C=C5)OC(C6=C4C=CC=C6)=O)=O)=C(C(COC(C7=CN(C8=C(C7=O)C=C(F)C(N9CCNCC9)=C8)CC)=O)=C1)OCC%10=CC=C(C=C%10)[N+]([O-])=O
Molecular Formula
C57H52FN5O12
Molecular Weight
1018.05
References & Citations
[1]Sanu Karan, et al. Hypoxia-Directed and Self-Immolative Theranostic Agent: Imaging and Treatment of Cancer and Bacterial Infections. J Med Chem. 2023, 66, 20.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
P5750-03-PE 200 µL
PRDM3 (MDS1 and EVI1 Complex Locus Protein EVI1, Ecotropic Virus Integration Site 1 Protein Homolog, EVI-1, MECOM, Myelodysplasia Syndrome 1 Protein, Myelodysplasia Syndrome-associated Protein 1) (PE) discontinued
Sign In for Pricing
View Details